FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898093986> ?p ?o ?g. }

• W2898093986 endingPage "52" @default.
• W2898093986 startingPage "44" @default.
• W2898093986 abstract "Objectives Complex regional pain syndrome (CRPS) and associated comorbidities have been linked to a pro-inflammatory state driven by different mediators. Targeted dorsal root ganglion stimulation (DRGSTIM) suppressed pain levels and improved functional capacity in intractable CRPS. However, clinical trials assessing the impact of DRG stimulation on the neuroimmune axis are lacking. Methods This study enrolled 24 subjects (12 refractory CRPS patients plus suitably matched healthy controls) and performed immunoassays of inflammatory mediators in saliva and serum along with score-based assessments of pain, mood, and sleep quality at baseline and after three months of selective L4-DRGSTIM. Results After three-month L4-DRGSTIM CRPS associated pain significantly decreased. In addition, disturbed sleep and mood improved post-DRGSTIM, although statistically not significant. Significantly increased serum values of pro-inflammatory markers were detected pre- and post L4-DRGSTIM for high-mobility group box 1, tumor-necrosis factor α, interleukin (IL) 6, and leptin. IL-1β was significantly elevated pre-L4 DRGSTIM, but not posttreatment. Elevated anti-inflammatory IL-10 significantly decreased after three months in serum, while saliva oxytocin concentrations increased in CRPS subjects after L4-DRGSTIM (p = 0.65). No severe implantation and stimulation associated adverse events were recorded. Conclusions Selective L4-DRGSTIM improved neuropathic pain and functional impairment in CRPS as previously reported. CRPS patients displayed a pro-inflammatory molecular pattern in serum. Serum anti-inflammatory IL-10 significantly declined, while saliva oxytocin nonsignificantly increased after L4-DRGSTIM. An evidence-based relational interpretation of our study is limited due to the uncontrolled study design. However, molecular profiling of biofluids (saliva, serum) represents a novel and experimental field in applied neuromodulation, which warrant further investigations to unveil mechanisms of neuroimmune modulation. Complex regional pain syndrome (CRPS) and associated comorbidities have been linked to a pro-inflammatory state driven by different mediators. Targeted dorsal root ganglion stimulation (DRGSTIM) suppressed pain levels and improved functional capacity in intractable CRPS. However, clinical trials assessing the impact of DRG stimulation on the neuroimmune axis are lacking. This study enrolled 24 subjects (12 refractory CRPS patients plus suitably matched healthy controls) and performed immunoassays of inflammatory mediators in saliva and serum along with score-based assessments of pain, mood, and sleep quality at baseline and after three months of selective L4-DRGSTIM. After three-month L4-DRGSTIM CRPS associated pain significantly decreased. In addition, disturbed sleep and mood improved post-DRGSTIM, although statistically not significant. Significantly increased serum values of pro-inflammatory markers were detected pre- and post L4-DRGSTIM for high-mobility group box 1, tumor-necrosis factor α, interleukin (IL) 6, and leptin. IL-1β was significantly elevated pre-L4 DRGSTIM, but not posttreatment. Elevated anti-inflammatory IL-10 significantly decreased after three months in serum, while saliva oxytocin concentrations increased in CRPS subjects after L4-DRGSTIM (p = 0.65). No severe implantation and stimulation associated adverse events were recorded. Selective L4-DRGSTIM improved neuropathic pain and functional impairment in CRPS as previously reported. CRPS patients displayed a pro-inflammatory molecular pattern in serum. Serum anti-inflammatory IL-10 significantly declined, while saliva oxytocin nonsignificantly increased after L4-DRGSTIM. An evidence-based relational interpretation of our study is limited due to the uncontrolled study design. However, molecular profiling of biofluids (saliva, serum) represents a novel and experimental field in applied neuromodulation, which warrant further investigations to unveil mechanisms of neuroimmune modulation." @default.
• W2898093986 created "2018-11-02" @default.
• W2898093986 creator A5000599518 @default.
• W2898093986 creator A5002687802 @default.
• W2898093986 creator A5004090819 @default.
• W2898093986 creator A5011557766 @default.
• W2898093986 creator A5016523064 @default.
• W2898093986 creator A5029544294 @default.
• W2898093986 creator A5032096711 @default.
• W2898093986 creator A5042501649 @default.
• W2898093986 creator A5043542110 @default.
• W2898093986 creator A5046992579 @default.
• W2898093986 creator A5048321390 @default.
• W2898093986 creator A5051162303 @default.
• W2898093986 creator A5054007397 @default.
• W2898093986 creator A5064253450 @default.
• W2898093986 creator A5065335863 @default.
• W2898093986 creator A5073080904 @default.
• W2898093986 creator A5074274819 @default.
• W2898093986 date "2019-01-01" @default.
• W2898093986 modified "2023-10-15" @default.
• W2898093986 title "Selective L4 Dorsal Root Ganglion Stimulation Evokes Pain Relief and Changes of Inflammatory Markers: Part I Profiling of Saliva and Serum Molecular Patterns" @default.
• W2898093986 cites W1508760004 @default.
• W2898093986 cites W1566587395 @default.
• W2898093986 cites W1983374902 @default.
• W2898093986 cites W1990076794 @default.
• W2898093986 cites W1992047131 @default.
• W2898093986 cites W2007671028 @default.
• W2898093986 cites W2015494919 @default.
• W2898093986 cites W2017916841 @default.
• W2898093986 cites W2021163482 @default.
• W2898093986 cites W2043946280 @default.
• W2898093986 cites W2045437093 @default.
• W2898093986 cites W2060898555 @default.
• W2898093986 cites W2065227289 @default.
• W2898093986 cites W2067495470 @default.
• W2898093986 cites W2086195789 @default.
• W2898093986 cites W2090754553 @default.
• W2898093986 cites W2103699850 @default.
• W2898093986 cites W2126705878 @default.
• W2898093986 cites W2127944199 @default.
• W2898093986 cites W2132072683 @default.
• W2898093986 cites W2135235221 @default.
• W2898093986 cites W2138452800 @default.
• W2898093986 cites W2146655845 @default.
• W2898093986 cites W2151487996 @default.
• W2898093986 cites W2153521635 @default.
• W2898093986 cites W2171060388 @default.
• W2898093986 cites W2263692701 @default.
• W2898093986 cites W2292055541 @default.
• W2898093986 cites W2346848910 @default.
• W2898093986 cites W2394997678 @default.
• W2898093986 cites W2409683891 @default.
• W2898093986 cites W2547814918 @default.
• W2898093986 cites W2564952377 @default.
• W2898093986 cites W2574931362 @default.
• W2898093986 cites W2698307513 @default.
• W2898093986 cites W2741223047 @default.
• W2898093986 cites W2757921639 @default.
• W2898093986 cites W2758618690 @default.
• W2898093986 cites W2760380281 @default.
• W2898093986 cites W2765825911 @default.
• W2898093986 cites W2769394821 @default.
• W2898093986 cites W2790571424 @default.
• W2898093986 cites W2790987764 @default.
• W2898093986 cites W2794200373 @default.
• W2898093986 cites W627284875 @default.
• W2898093986 doi "https://doi.org/10.1111/ner.12866" @default.
• W2898093986 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30358008" @default.
• W2898093986 hasPublicationYear "2019" @default.
• W2898093986 type Work @default.
• W2898093986 sameAs 2898093986 @default.
• W2898093986 citedByCount "26" @default.
• W2898093986 countsByYear W28980939862019 @default.
• W2898093986 countsByYear W28980939862020 @default.
• W2898093986 countsByYear W28980939862021 @default.
• W2898093986 countsByYear W28980939862022 @default.
• W2898093986 countsByYear W28980939862023 @default.
• W2898093986 crossrefType "journal-article" @default.
• W2898093986 hasAuthorship W2898093986A5000599518 @default.
• W2898093986 hasAuthorship W2898093986A5002687802 @default.
• W2898093986 hasAuthorship W2898093986A5004090819 @default.
• W2898093986 hasAuthorship W2898093986A5011557766 @default.
• W2898093986 hasAuthorship W2898093986A5016523064 @default.
• W2898093986 hasAuthorship W2898093986A5029544294 @default.
• W2898093986 hasAuthorship W2898093986A5032096711 @default.
• W2898093986 hasAuthorship W2898093986A5042501649 @default.
• W2898093986 hasAuthorship W2898093986A5043542110 @default.
• W2898093986 hasAuthorship W2898093986A5046992579 @default.
• W2898093986 hasAuthorship W2898093986A5048321390 @default.
• W2898093986 hasAuthorship W2898093986A5051162303 @default.
• W2898093986 hasAuthorship W2898093986A5054007397 @default.
• W2898093986 hasAuthorship W2898093986A5064253450 @default.
• W2898093986 hasAuthorship W2898093986A5065335863 @default.
• W2898093986 hasAuthorship W2898093986A5073080904 @default.
• W2898093986 hasAuthorship W2898093986A5074274819 @default.
• W2898093986 hasConcept C118552586 @default.
• W2898093986 hasConcept C126322002 @default.

• next